---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-002894"
form_type: "8-K"
ticker: "IMCR"
cik: "0001671927"
company_name: "Immunocore Holdings plc"
filed_at: "2026-01-30T23:59:59+00:00"
generated_at: "2026-05-16T05:58:56.281140+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Immunocore R&D Head David Berman resigns effective Feb 27; no replacement planned

## Summary
- David Berman notified resignation as Head of R&D on Jan 27, 2026, effective Feb 27, 2026.
- Resignation is voluntary to pursue another opportunity; not due to any disagreement with the Company.
- Company will not seek a direct replacement; will streamline and leverage existing R&D structure.

## SEC filing metadata
- accession: 0001140361-26-002894
- form_type: 8-K
- ticker: IMCR
- cik: 0001671927
- company_name: Immunocore Holdings plc
- filed_at: 2026-01-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671927/000114036126002894/0001140361-26-002894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671927/000114036126002894/ef20064300_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-002894
- JSON: https://secwatch.observer/filing/0001140361-26-002894.json
- Plain text: https://secwatch.observer/filing/0001140361-26-002894.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.